Jefferies Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $21.3M | Buy |
65,900
+40,900
| +164% | +$13M | 0.18% | 91 |
|
|
2022
Q2 | $8.11M | Hold |
25,000
| – | – | 0.07% | 239 |
|
|
2022
Q1 | $7.16M | Buy |
25,000
+12,600
| +102% | +$3.24M | 0.05% | 318 |
|
|
2021
Q4 | $3.43M | Buy |
+12,400
| New | +$3.14M | 0.02% | 605 |
|
|
2021
Q3 | – | Sell |
-7,000
| Closed | -$1.61M | – | 1881 |
|
|
2021
Q2 | $1.61M | Buy |
+7,000
| New | +$1.41M | 0.01% | 823 |
|
|
2020
Q3 | – | Sell |
-30,000
| Closed | -$4.92K | – | 1462 |
|
|
2020
Q2 | $4.92K | Sell |
30,000
-2,000
| -6% | -$307K | 0.06% | 276 |
|
|
2020
Q1 | $4.44M | Sell |
32,000
-51,300
| -62% | -$7.05M | 0.05% | 363 |
|
|
2019
Q4 | $10.9M | Buy |
83,300
+66,200
| +387% | +$7.67M | 0.08% | 204 |
|
|
2019
Q3 | $1.91M | Sell |
17,100
-16,000
| -48% | -$1.78M | 0.01% | 1122 |
|
|
2019
Q2 | $3.67M | Sell |
33,100
-37,000
| -53% | -$4.36M | 0.03% | 617 |
|
|
2019
Q1 | $9.1M | Buy |
70,100
+46,600
| +198% | +$5.67M | 0.07% | 230 |
|
|
2018
Q4 | $2.72M | Sell |
23,500
-54,800
| -70% | -$6.12M | 0.02% | 680 |
|
|
2018
Q3 | $8.4M | Sell |
78,300
-37,900
| -33% | -$3.79M | 0.05% | 326 |
|
|
2018
Q2 | $9.91M | Buy |
116,200
+75,200
| +183% | +$6.18M | 0.06% | 266 |
|
|
2018
Q1 | $3.17M | Sell |
41,000
-72,800
| -64% | -$5.86M | 0.02% | 657 |
|
|
2017
Q4 | $9.61M | Sell |
113,800
-20,800
| -15% | -$1.77M | 0.05% | 320 |
|
|
2017
Q3 | $11.5M | Sell |
134,600
-19,900
| -13% | -$1.63M | 0.08% | 238 |
|
|
2017
Q2 | $12.7M | Sell |
154,500
-152,100
| -50% | -$12.4M | 0.08% | 216 |
|
|
2017
Q1 | $25.8M | Buy |
306,600
+124,100
| +68% | +$9.94M | 0.19% | 81 |
|
|
2016
Q4 | $13.4M | Sell |
182,500
-35,300
| -16% | -$2.63M | 0.08% | 261 |
|
|
2016
Q3 | $17.5M | Buy |
217,800
+210,500
| +2,884% | +$16.8M | 0.09% | 175 |
|
|
2016
Q2 | $575K | Sell |
7,300
-8,300
| -53% | -$625K | ﹤0.01% | 1375 |
|
|
2016
Q1 | $1.12M | Sell |
15,600
-435,400
| -97% | -$32.9M | 0.01% | 1091 |
|
|
2015
Q4 | $38M | Buy |
451,000
+11,100
| +3% | +$921K | 0.22% | 78 |
|
|
2015
Q3 | $36.8M | Sell |
439,900
-77,100
| -15% | -$6.51M | 0.21% | 81 |
|
|
2015
Q2 | $43.2M | Sell |
517,000
-223,800
| -30% | -$17.1M | 0.22% | 72 |
|
|
2015
Q1 | $53.8M | Buy |
740,800
+694,300
| +1,493% | +$49.4M | 0.3% | 45 |
|
|
2014
Q4 | $3.21M | Sell |
46,500
-226,600
| -83% | -$15.3M | 0.02% | 545 |
|
|
2014
Q3 | $17.7M | Buy |
+273,100
| New | +$17.3M | 0.12% | 154 |
|
|
2014
Q1 | – | Sell |
-67,500
| Closed | -$3.44M | – | 2229 |
|
|
2013
Q4 | $3.44M | Buy |
67,500
+51,800
| +330% | +$2.59M | 0.02% | 409 |
|
|
2013
Q3 | $790K | Buy |
+15,700
| New | +$822K | 0.01% | 1015 |
|
Other funds holding LLY
Jefferies Group's LLY Position: Q3 2022 in Review
Jefferies Group reduced its Eli Lilly (LLY) stake by 25% in Q3 2022, selling an estimated $7.09M and leaving 67,267 shares worth $21.8M. The position accounts for 0.18% of the portfolio, ranked #87.
Jefferies Group first reported a position in LLY in Q2 2013 and has held it in 38 quarters since. The position peaked at $29.1M in Q2 2022. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.
- Jefferies Group held 67,267 shares of Eli Lilly worth $21.8M as of Q3 2022.
- Jefferies Group sold 22,387 Eli Lilly shares in Q3 2022, an estimated $7.09M.
- Eli Lilly made up 0.18% of Jefferies Group's portfolio in Q3 2022, its #87 holding.
- Jefferies Group first reported a position in Eli Lilly in Q2 2013 and has held it in 38 quarters since.
- Jefferies Group's Eli Lilly position peaked at $29.1M in Q2 2022.
- 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.